EICHOR
● Active Not Recruiting
A Study to Evaluate How the Study Drug Moves Through the Body, Adverse Events, and How the Body Tolerates ABBV-547 Injections
Condition: Healthy Volunteer · Sponsor: AbbVie
About this study
The purpose of this study is to assess how safe, effective, and tolerable ABBV-547 is in adult participants in the United States and Japan. There will be 2 parts to this study. In Part 1, participants are placed in one of 7 groups where they will receive ABBV-547 at different doses or placebo. There is a 1 in 4 chance participants will receive placebo. In Part 2, participants are placed in one of 3 groups where they will receive ABBV-547 at different doses or placebo. There is a 1 in 7 chance participants will receive placebo. Approximately 121 adult participants will be enrolled at approximately 21 sites in the United States and Japan. Participants will be administered one dose of ABBV-547 or placebo. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (23)
| Total Dermatology /ID# 279798 | Birmingham, Alabama, United States | — |
| Dermatology Trial Associates /ID# 279984 | Bryant, Arkansas, United States | — |
| CenExel ACT- Anaheim Clinical Trials /ID# 279612 | Anaheim, California, United States | — |
| Dermatology Research Associates - Los Angeles /ID# 279383 | Los Angeles, California, United States | — |
| Integrative Skin Science and Research - Location 2 /ID# 279386 | Sacramento, California, United States | — |
| Skin Care Research Boca Raton /ID# 279988 | Boca Raton, Florida, United States | — |
| Wellness Clinical Research - Miami Lakes /ID# 279803 | Miami Lakes, Florida, United States | — |
| Advanced Clinical Research Institute - Tampa /ID# 279342 | Tampa, Florida, United States | — |
| Trueblue Clinical Research - Tampa /ID# 281757 | Tampa, Florida, United States | — |
| University Dermatology & Vein Clinic - Darien /ID# 279986 | Darien, Illinois, United States | — |
| Acpru /Id# 278638 | Grayslake, Illinois, United States | — |
| MetroBoston Clinical Partners /ID# 279992 | Boston, Massachusetts, United States | — |
+ 11 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07232004